Identification and management of subclinical disease activity in early multiple sclerosis: a review Daniel OntanedaTanuja ChitnisAhmed Z. Obeidat Review Open access 21 October 2023 Pages: 1497 - 1514
Key characteristics of anti-CD20 monoclonal antibodies and clinical implications for multiple sclerosis treatment Silvia R. DelgadoSimon FaissnerKottil Rammohan Review Open access 31 October 2023 Pages: 1515 - 1535
Nutritional interventional studies in patients with multiple sclerosis: a scoping review of the current clinical evidence Christina TryfonosMaria ChrysafiConstantinos Giaginis Review 04 January 2024 Pages: 1536 - 1570
Cognitive phenotypes in multiple sclerosis: mapping the spectrum of impairment Damiano MistriNicolò TedoneMassimo Filippi Original Communication 26 November 2023 Pages: 1571 - 1583
Body mass, neuro-hormonal stress processing, and disease activity in lean to obese people with multiple sclerosis Lil Meyer-ArndtJelena BrasanacMartin Weygandt Original Communication 27 November 2023 Pages: 1584 - 1598
Baseline serum neurofilament light chain levels differentiate aggressive from benign forms of relapsing–remitting multiple sclerosis: a 20-year follow-up cohort Pablo Arroyo PereiroAlbert Muñoz-VendrellPol Andrés-Benito Original Communication Open access 12 December 2023 Pages: 1599 - 1609
Increasing age of multiple sclerosis onset from 1920 to 2022: a population-based study A. HabbestadJ. S. WillumsenØ. Torkildsen Original Communication Open access 14 December 2023 Pages: 1610 - 1617
Monoaminergic network dysfunction and development of depression in multiple sclerosis: a longitudinal investigation Damiano MistriPaola ValsasinaMaria A. Rocca Original Communication 19 December 2023 Pages: 1618 - 1629
Late-onset multiple sclerosis: disability trajectories in relapsing–remitting patients of the Italian MS Registry Lorena LoreficeOttavia Elena Ferrarothe Italian MS Register Original Communication 03 January 2024 Pages: 1630 - 1637
Free-living ambulatory physical activity and cognitive function in multiple sclerosis: the significance of step rate vs. step volume Peixuan ZhengBrian M. SandroffRobert W. Motl Original Communication 12 January 2024 Pages: 1638 - 1648
Neurophysiological brain function predicts response to cognitive rehabilitation and mindfulness in multiple sclerosis: a randomized trial Ilse M. NautaRoy P. C. KesselsBrigit A. de Jong Original Communication Open access 26 January 2024 Pages: 1649 - 1662
Tumefactive demyelinating lesions: a challenging first manifestation of multiple sclerosis Matteo AzzimontiMonica MargoniMassimo Filippi Letter to the Editors 28 December 2023 Pages: 1663 - 1667
Evaluation and management of insomnia in the clinical practice in Italy: a 2023 update from the Insomnia Expert Consensus Group Laura PalaginiRaffaele ManniLuigi Ferini-Strambi Review 08 December 2023 Pages: 1668 - 1679
Analysis of biomarkers in speculative CNS-enriched extracellular vesicles for parkinsonian disorders: a comprehensive systematic review and diagnostic meta-analysis Hash Brown TahaAleksander Bogoniewski Review Open access 16 December 2023 Pages: 1680 - 1706
Differentiating anti-IgLON5 disease and Lewy body dementia: a systematic review Oskar McWilliamMathias H. GramkowKristian Steen Frederiksen Review 09 January 2024 Pages: 1707 - 1716
Multisensory hallucinations and other unusual sensory experiences in the context of migraine: a systematic review Yixuan LiCaitlin O. B. YollandWei Lin Toh Review Open access 18 January 2024 Pages: 1717 - 1746
Chronic lymphocytic inflammation with pontine perivascular enhancement responsive to steroids (CLIPPERS): contemporary advances and current controversies Er-Chuang LiQi-Lun LaiYin-Xi Zhang Review 29 January 2024 Pages: 1747 - 1766
Structural brain heterogeneity underlying symptomatic and asymptomatic genetic dystonia: a multimodal MRI study Aleksandra TomićElisabetta SarassoFederica Agosta Original Communication 29 November 2023 Pages: 1767 - 1775
Upper and lower limb tremor in Charcot–Marie–Tooth neuropathy type 1A and the implications for standing balance Matthew SilsbyCon YiannikasSteve Vucic Original Communication Open access 05 December 2023 Pages: 1776 - 1786
Long-term safety and efficacy of cipaglucosidase alfa plus miglustat in individuals living with Pompe disease: an open-label phase I/II study (ATB200-02) Barry J. ByrneBenedikt SchoserTahseen Mozaffar Original Communication Open access 06 December 2023 Pages: 1787 - 1801
A retrospective study of accuracy and usefulness of electrophysiological exercise tests Vesa PeriviitaManu JokelaBjarne Udd Original Communication Open access 06 December 2023 Pages: 1802 - 1812
The brief repeatable battery of neuropsychological tests (BRB-N) version a: update of Italian normative data from the Italian Neuroimaging Network Initiative (INNI) Nicolò TedoneCarmen VizzinoMassimo Filippi Original Communication 07 December 2023 Pages: 1813 - 1823
Reduced tear fluid production in neurological diseases: a cohort study in 708 patients Elena LuibAntonia F. DemleitnerPaul Lingor Original Communication Open access 08 December 2023 Pages: 1824 - 1836
Relationship between plasma NFL and disease progression in Parkinson’s disease: a prospective cohort study Ruwei OuKuncheng LiuHuifang Shang Original Communication 08 December 2023 Pages: 1837 - 1843
Frataxin analysis using triple quadrupole mass spectrometry: application to a large heterogeneous clinical cohort David R. LynchTeerapat RojsajjakulIan A. Blair Original Communication 08 December 2023 Pages: 1844 - 1849
Evidence for converging pathophysiology in complex regional pain-syndrome and primary headache disorders: results from a case–control study Matthias WiemannNikolas ZimowskiSebastian Strauss Original Communication Open access 09 December 2023 Pages: 1850 - 1860
Expanding clinical profiles and prognostic markers in stiff person syndrome spectrum disorders Yujie WangChen HuScott D. Newsome Original Communication Open access 11 December 2023 Pages: 1861 - 1872
Routine outcomes and evaluation of an 8-week outpatient multidisciplinary rehabilitative therapy program for functional neurological disorder Lisette GuyGabriella A. CaceresSusannah Pick Original Communication Open access 13 December 2023 Pages: 1873 - 1884
Basilar artery occlusion: drip-and-ship versus direct-to-center for mechanical thrombectomy within the Neurovascular Network of Southwest Bavaria (NEVAS) Ilias MasourisJ. WischmannF. Schöberl Original Communication 14 December 2023 Pages: 1885 - 1892
Genotype–phenotype correlations of neurofibromatosis type 1: a cross-sectional study from a large Chinese cohort Beiyao ZhuTingting ZhengZhichao Wang Original Communication 14 December 2023 Pages: 1893 - 1900
Pretreatment parameters associated with hemorrhagic transformation among successfully recanalized medium vessel occlusions Manisha KoneruMeisam HoseinyazdiVivek S. Yedavalli Original Communication 15 December 2023 Pages: 1901 - 1909
Neuroimaging correlates of postural instability in Parkinson’s disease Andrea QuattroneCamilla CalominoAldo Quattrone Original Communication 18 December 2023 Pages: 1910 - 1920
Genetics screening in an Italian cohort of patients with Amyotrophic Lateral Sclerosis: the importance of early testing and its implication Laura LibonatiChiara CambieriMarco Ceccanti Original Communication 19 December 2023 Pages: 1921 - 1936
Next-generation sequencing and comprehensive data reassessment in 263 adult patients with neuromuscular disorders: insights into the gray zone of molecular diagnoses Martin KrennMatias WagnerJakob Rath Original Communication Open access 21 December 2023 Pages: 1937 - 1946
Immune checkpoint inhibitor-related myositis and myocarditis: diagnostic pitfalls and imaging contribution in a real-world, institutional case series Alex VicinoAndreas F. HottingerMarie Théaudin Original Communication Open access 23 December 2023 Pages: 1947 - 1958
Clinical features and neurobiochemical mechanisms of olfactory dysfunction in patients with Parkinson disease Ruidan WangTenghong LianWei Zhang Original Communication 27 December 2023 Pages: 1959 - 1972
Impact of demographics and comorbid conditions on plasma biomarkers concentrations and their diagnostic accuracy in a memory clinic cohort Jordi SartoDiana Esteller-GauxaxMircea Balasa Original Communication 27 December 2023 Pages: 1973 - 1984
An exploratory study on the association between blood-based biomarkers and subacute neurometabolic changes following mild traumatic brain injury Koen VisserMyrthe E. de KoningHarm Jan van der Horn Original Communication 29 December 2023 Pages: 1985 - 1998
Cerebrospinal fluid NPTX2 changes and relationship with regional brain metabolism metrics across mild cognitive impairment due to Alzheimer's disease Federico MassaCaterina MartinuzzoMatteo Pardini Original Communication 29 December 2023 Pages: 1999 - 2009
An interactive web application to identify early Parkinsonian non-tremor-dominant subtypes Xiaozhou XuWen GuLishun Xiao Original Communication 04 January 2024 Pages: 2010 - 2018
Estimating motor progression trajectory pursuant to temporal dynamic status of cardiac denervation in Parkinson’s disease Sang-Won YooDong-Woo RyuJoong-Seok Kim Original Communication 06 January 2024 Pages: 2019 - 2030
Dual-task gait training improves cognition and resting-state functional connectivity in Parkinson’s disease with postural instability and gait disorders Michela LeocadiElisa CanuFederica Agosta Original Communication 08 January 2024 Pages: 2031 - 2041
Plasma neurofilament light as a promising biomarker in neuronal intranuclear inclusion disease Minglei LiuYuru ZhuJing Yang Original Communication 08 January 2024 Pages: 2042 - 2052
Head-to-head study of diagnostic accuracy of plasma and cerebrospinal fluid p-tau217 versus p-tau181 and p-tau231 in a memory clinic cohort Augusto J. MendesFederica RibaldiGiovanni B. Frisoni Original Communication Open access 09 January 2024 Pages: 2053 - 2066
Prediction of cognitive decline in healthy aging based on neuropsychiatric symptoms and PET-biomarkers of Alzheimer's disease Lucas RonatAlexandru HanganuChristine Bastin Short Commentary 19 December 2023 Pages: 2067 - 2077
Does Spinocerebellar ataxia 27B mimic cerebellar multiple system atrophy? Thomas WirthCéline BonnetMathieu Anheim Short Commentary 23 January 2024 Pages: 2078 - 2085
ChatGPT fails challenging the recent ESCMID brain abscess guideline Susanne Dyckhoff-ShenUwe KoedelMatthias Klein Short Commentary Open access 27 January 2024 Pages: 2086 - 2101
How neurologists are viewed by their colleagues: exploring stereotypes and social representations of neurologists Margaux ChevalAymeric LanoreNawale Hadouiri Letter to the Editors 15 November 2023 Pages: 2102 - 2107
Plasma GFAP and its association with disease severity in Huntington’s disease Kübra TanMelanie AlpaughAndréa L. Benedet Letter to the Editors 18 November 2023 Pages: 2108 - 2113
Myelitis as a side effect of tofersen therapy in SOD1-associated ALS Peter ReilichFlorian SchöberlMakbule Senel Letter to the Editors Open access 09 December 2023 Pages: 2114 - 2118
